Browse by UCL Departments and Centres
Group by: Author | Type
Number of items: 132.
A
Abbosh, C;
Birkbak, NJ;
Wilson, GA;
Jamal-Hanjani, M;
Constantin, T;
Salari, R;
Le Quesne, J;
... Dessimoz, C; + view all
(2017)
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.
Nature
, 545
pp. 446-451.
10.1038/nature22364.
|
Abraham, BJ;
Hnisz, D;
Weintraub, AS;
Kwiatkowski, N;
Li, CH;
Li, Z;
Weichert-Leahey, N;
... Young, RA; + view all
(2017)
Small genomic insertions form enhancers that misregulate oncogenes.
Nature Communications
, 8
, Article 14385. 10.1038/ncomms14385.
|
Abrol, E;
Groszmann, M;
Pitman, A;
Hough, R;
Taylor, RM;
Aref-Adib, G;
(2017)
Exploring the digital technology preferences of teenagers and young adults (TYA) with cancer and survivors: a cross-sectional service evaluation questionnaire.
Journal of Cancer Survivorship
, 11
(6)
pp. 670-682.
10.1007/s11764-017-0618-z.
|
Afaq, A;
Fraioli, F;
Sidhu, H;
Wan, S;
Punwani, S;
Chen, S-H;
Akin, O;
... Kayani, I; + view all
(2017)
Comparison of PET/MRI With PET/CT in the Evaluation of Disease Status in Lymphoma.
Clinical Nuclear Medicine
, 42
(1)
e1-e7.
10.1097/RLU.0000000000001344.
|
Agliardi, Giulia;
(2017)
Development of a Chimeric Antigen Receptor (CAR) - based T cell therapy for glioblastoma.
Doctoral thesis (Ph.D), UCL (University College London).
|
Ali, A;
Gale, RE;
Shakoori, AR;
(2017)
Detection of FLT3/TKD and IDH1 Mutations in Pakistani Acute Myeloid Leukemia Patients by Denaturing HPLC.
Journal of Cellular Biochemistry
, 118
(5)
pp. 1174-1181.
10.1002/jcb.25761.
|
Ansari, T;
Lange, P;
Southgate, A;
Greco, K;
Carvalho, C;
Partington, L;
Bullock, A;
... Birchall, MA; + view all
(2017)
Stem Cell-Based Tissue-Engineered Laryngeal Replacement.
Stem Cells Translational Medicine
, 6
(2)
pp. 677-687.
10.5966/sctm.2016-0130.
|
Arends, M;
Biegstraaten, M;
Hughes, DA;
Mehta, A;
Elliott, PM;
Oder, D;
Watkinson, OT;
... Hollak, CEM; + view all
(2017)
Retrospective study of long-term outcomes of enzyme replacement therapy in Fabry disease: Analysis of prognostic factors.
PLoS One
, 12
(8)
, Article e0182379. 10.1371/journal.pone.0182379.
|
Arends, M;
Körver, S;
Hughes, DA;
Mehta, A;
Hollak, CEM;
Biegstraaten, M;
(2017)
Phenotype, disease severity and pain are major determinants of quality of life in Fabry disease: results from a large multicenter cohort study.
J Inherit Metab Dis
10.1007/s10545-017-0095-6.
(In press).
|
Artim-Esen, B;
Smoktunowicz, N;
McDonnell, T;
Ripoll, VM;
Pericleous, C;
Mackie, I;
Robinson, E;
... Giles, I; + view all
(2017)
Factor Xa Mediates Calcium Flux in Endothelial Cells and is Potentiated by Igg From Patients With Lupus and/or Antiphospholipid Syndrome.
Scientific Reports
, 7
(1)
, Article 10788. 10.1038/s41598-017-11315-9.
|
B
Banerjee, G;
Wilson, D;
Ambler, G;
Osei-Bonsu Appiah, K;
Shakeshaft, C;
Lunawat, S;
Cohen, H;
... CROMIS-2 Collaborators; + view all
(2017)
Cognitive Impairment Before Intracerebral Hemorrhage Is Associated With Cerebral Amyloid Angiopathy.
Stroke
, 49
pp. 40-45.
10.1161/STROKEAHA.117.019409.
|
Belmatoug, N;
Di Rocco, M;
Fraga, C;
Giraldo, P;
Hughes, D;
Lukina, E;
Maison-Blanche, P;
... Cox, TM; + view all
(2017)
Management and monitoring recommendations for the use of eliglustat in adults with type 1 Gaucher disease in Europe.
[Review].
European Journal of Internal Medicine
, 37
pp. 25-32.
10.1016/j.ejim.2016.07.011.
|
Benjamin, ER;
Della Valle, MC;
Wu, X;
Katz, E;
Pruthi, F;
Bond, S;
Bronfin, B;
... Lockhart, DJ; + view all
(2017)
The validation of pharmacogenetics for the identification of Fabry patients to be treated with migalastat.
Genetics in Medicine
, 19
(4)
pp. 430-438.
10.1038/gim.2016.122.
|
Berlato, C;
Khan, MN;
Schioppa, T;
Thompson, R;
Maniati, E;
Montfort, A;
Jangani, M;
... Balkwill, FR; + view all
(2017)
A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer.
Journal of Clinical Investigation
, 127
(3)
pp. 801-813.
10.1172/JCI82976.
|
Bharucha, T;
Rutherford, A;
Skeoch, S;
Alavi, A;
Brown, M;
Galloway, J;
FDG-PET/CT in fever of unknown origin working group;
(2017)
Diagnostic yield of FDG-PET/CT in fever of unknown origin: a systematic review, meta-analysis, and Delphi exercise.
Clinical Radiology
, 72
(9)
pp. 764-771.
10.1016/j.crad.2017.04.014.
|
Bird, S;
Hadjimichael, E;
Mehta, A;
Ramaswami, U;
Hughes, D;
(2017)
Fabry disease and incidence of cancer.
Orphanet Journal of Rare Diseases
, 12
(1)
, Article 150. 10.1186/s13023-017-0701-6.
|
Boto, C;
Quartin, E;
Cai, Y;
Martin-Lorenzo, A;
Garcia Cenador, MB;
Pinto, S;
Gupta, R;
... Ferreira, L; + view all
(2017)
Prolonged intracellular accumulation of light-inducible nanoparticles in leukemia cells allows their remote activation.
Nature Communications
, 8
, Article 15204. 10.1038/ncomms15204.
|
Butler, CR;
Hynds, RE;
Crowley, C;
Gowers, KH;
Partington, L;
Hamilton, NJ;
Carvalho, C;
... Janes, SM; + view all
(2017)
Vacuum-assisted decellularization: an accelerated protocol to generate tissue-engineered human tracheal scaffolds.
Biomaterials
, 124
pp. 95-105.
10.1016/j.biomaterials.2017.02.001.
|
Byrne, BJ;
Geberhiwot, T;
Barshop, BA;
Barohn, R;
Hughes, D;
Bratkovic, D;
Desnuelle, C;
... Walsh, L; + view all
(2017)
A study on the safety and efficacy of reveglucosidase alfa in patients with late-onset Pompe disease.
Orphanet Journal of Rare Diseases
, 12
, Article 144. 10.1186/s13023-017-0693-2.
|
C
Cavenagh, J;
Oakervee, H;
Baetiong-Caguioa, P;
Davies, F;
Gharibo, M;
Rabin, N;
Kurman, M;
... Yong, K; + view all
(2017)
A phase I/II study of KW-2478, an Hsp90 inhibitor, in combination with bortezomib in patients with relapsed/refractory multiple myeloma.
British Journal of Cancer
, 117
(9)
pp. 1295-1302.
10.1038/bjc.2017.302.
|
Chandran, S;
Watkins, J;
Abdul‐Aziz, A;
Shafat, M;
Calvert, PA;
Bowles, KM;
Flather, MD;
... Ryding, AD; + view all
(2017)
Inflammatory Differences in Plaque Erosion and Rupture in Patients With ST‐Segment Elevation Myocardial Infarction.
Journal of the American Heart Association
, 6
(5)
, Article e005868. 10.1161/JAHA.117.005868.
|
Chin, M;
Sive, JI;
Allen, C;
Roddie, C;
Chavda, SJ;
Smith, D;
Blombery, P;
... Yong, KL; + view all
(2017)
Prevalence and timing of TP53 mutations in del(17p) myeloma and effect on survival.
Blood Cancer Journal
, 7
, Article e610. 10.1038/bcj.2017.76.
|
Cox, S;
Hurt, C;
Grenader, T;
Mukherjee, S;
Bridgewater, J;
Crosby, T;
(2017)
The prognostic value of derived neutrophil to lymphocyte ratio in oesophageal cancer treated with definitive chemoradiotherapy.
Radiotherapy and Oncology
, 125
(1)
pp. 154-159.
10.1016/j.radonc.2017.08.023.
|
Crosby, T;
Hurt, CN;
Falk, S;
Gollins, S;
Staffurth, J;
Ray, R;
Bridgewater, JA;
... Mukherjee, S; + view all
(2017)
Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/- cetuximab in oesophageal cancer.
British Journal of Cancer
, 116
pp. 709-716.
10.1038/bjc.2017.21.
|
D
Davis, BA;
Allard, S;
Qureshi, A;
Porter, JB;
Pancham, S;
Win, N;
Cho, G;
... British Society for Haematology, .; + view all
(2017)
Guidelines on red cell transfusion in sickle cell disease Part II: indications for transfusion.
British Journal of Haematology
, 176
(2)
pp. 192-209.
10.1111/bjh.14383.
|
De Ascensão Santos e Sousa, Pedro Miguel;
(2017)
A systems immunology approach to graft-versus-host disease.
Doctoral thesis , UCL (University College London).
|
Dias, J;
Axelband, F;
Lara, LS;
Muzi-Filho, H;
Vieyra, A;
(2017)
Is angiotensin-(3–4) (Val-Tyr), the shortest angiotensin II-derived peptide, opening new vistas on the renin–angiotensin system?
Journal of the Renin-Angiotensin-Aldosterone System
, 18
(1)
10.1177/1470320316689338.
|
Domogala, A;
Blundell, M;
Thrasher, A;
Lowdell, MW;
Madrigal, JA;
Saudemont, A;
(2017)
Natural killer cells differentiated in vitro from cord blood CD34(+) cells are more advantageous for use as an immunotherapy than peripheral blood and cord blood natural killer cells.
Cytotherapy
, 19
(6)
pp. 710-720.
10.1016/j.jcyt.2017.03.068.
|
E
Efthymiou, M;
Mackie, IJ;
Lane, P;
Erkan, D;
Cohen, H;
(2017)
High prevalence of activated protein C resistance associated with high avidity anti-protein C antibodies in various antiphospholipid syndrome clinical phenotypes.
In:
(Proceedings) ISTH 2017.
|
Elliott, MJ;
Butler, CR;
Varanou-Jenkins, A;
Partington, L;
Carvalho, C;
Samuel, E;
Crowley, C;
... Birchall, MA; + view all
(2017)
Tracheal Replacement Therapy with a Stem Cell-Seeded Graft: Lessons from Compassionate Use Application of a GMP-Compliant Tissue-Engineered Medicine.
Stem Cells Translational Medicine
, 6
(6)
pp. 1458-1464.
10.1002/sctm.16-0443.
|
Eyre, TA;
Phillips, EH;
Linton, KM;
Kassam, S;
Gibb, A;
Allibone, S;
Radford, J;
... Collins, GP; + view all
(2017)
Results of a multicentre UK-wide retrospective study evaluating the efficacy of brentuximab vedotin in relapsed, refractory classical Hodgkin lymphoma in the transplant naive setting.
British Journal of Haematology
, 179
(3)
pp. 471-479.
10.1111/bjh.14898.
|
F
Furness, CL;
Smith, L;
Morris, E;
Brocklehurst, C;
Daly, S;
Hough, RE;
(2017)
Cancer Patient Experience in the Teenage Young Adult Population-Key Issues and Trends Over Time: An Analysis of the United Kingdom National Cancer Patient Experience Surveys 2010-2014.
Journal of Adolescent and Young Adult Oncology
, 6
(3)
pp. 450-458.
10.1089/jayao.2016.0058.
|
G
Galleu, A;
Riffo-Vasquez, Y;
Trento, C;
Lomas, C;
Dolcetti, L;
Cheung, TS;
von Bonin, M;
... Dazzi, F; + view all
(2017)
Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation.
Science Translational Medicine
, 9
(416)
, Article eaam7828. 10.1126/scitranslmed.aam7828.
|
Ganeshan, B;
Miles, KA;
Babikir, S;
Shortman, R;
Afaq, A;
Ardeshna, KM;
Groves, AM;
(2017)
CT-based texture analysis potentially provides prognostic information complementary to interim fdg-pet for patients with hodgkin's and aggressive non-hodgkin's lymphomas.
European Radiology
, 27
(3)
pp. 1012-1020.
10.1007/s00330-016-4470-8.
|
Garbowski, MW;
(2017)
Molecular and clinical factors affecting myocardial iron retention in transfusional haemosiderosis.
Doctoral thesis , UCL (University College London).
|
Garbowski, MW;
Evans, P;
Vlachodimitropoulou, E;
Hider, R;
Porter, JB;
(2017)
Residual erythropoiesis protects against myocardial hemosiderosis in transfusion-dependent thalassemia by lowering labile plasma iron via transient generation of apotransferrin.
Haematologica
, 102
pp. 1640-1649.
10.3324/haematol.2017.170605.
|
Gardiner, C;
Kohama, K;
Patel, I;
Lane, P;
Dwyer, S;
Machin, SJ;
Mackie, IJ;
(2017)
A performance evaluation of a novel human recombinant tissue factor prothrombin time reagent (Revohem (TM) PT).
International Journal of Laboratory Hematology
, 39
(5)
pp. 532-538.
10.1111/ijlh.12691.
|
Ghorani, E;
Kaur, B;
Fisher, RA;
Short, D;
Joneborg, U;
Carlson, JW;
Akarca, A;
... Seckl, MJ; + view all
(2017)
Pembrolizumab is effective for drugresistant gestational trophoblastic neoplasia.
The Lancet
, 390
(10110)
pp. 2343-2345.
10.1016/S0140-6736(17)32894-5.
|
Gleeson, M;
Counsell, N;
Cunningham, D;
Chadwick, N;
Lawrie, A;
Hawkes, EA;
McMillan, A;
... Linch, D; + view all
(2017)
Central nervous system relapse of diffuse large B-cell lymphoma in the rituximab era: results of the UK NCRI R-CHOP-14 versus 21 trial.
Annals of Oncology
, 28
(10)
pp. 2511-2516.
10.1093/annonc/mdx353.
|
Goel, A;
Raghupathy, V;
Amirtharaj, GJ;
Chapla, A;
Venkatraman, A;
Ramakrishna, B;
Ramachandran, A;
... Eapen, CE; + view all
(2017)
ADAMTS13 missense variants associated with defective activity and secretion of ADAMTS13 in a patient with non-cirrhotic portal hypertension.
Indian Journal of Gastroenterology
, 36
(5)
pp. 380-389.
10.1007/s12664-017-0786-9.
|
Gohil, SH;
Paredes-Moscosso, SR;
Harrasser, M;
Vezzalini, M;
Scarpa, A;
Morris, E;
Davidoff, AM;
... Della Peruta, M; + view all
(2017)
An ROR1 bi-specific T-cell engager provides effective targeting and cytotoxicity against a range of solid tumors.
OncoImmunology
, 6
(7)
, Article e1326437. 10.1080/2162402X.2017.1326437.
|
Goodship, THJ;
Pinto, F;
Weston-Davies, WH;
Silva, J;
Nishimura, J-I;
Nunn, MA;
Mackie, I;
... Veys, P; + view all
(2017)
Use of the complement inhibitor Coversin to treat HSCT-associated TMA.
Blood Advances
, 1
(16)
pp. 1254-1258.
10.1182/bloodadvances.2016002832.
|
Green, K;
Pearce, K;
Sellar, RS;
Jardine, L;
Nicolson, PLR;
Nagra, S;
Bigley, V;
... Collin, M; + view all
(2017)
Impact of Alemtuzumab Scheduling on Graft-versus-Host Disease after Unrelated Donor Fludarabine and Melphalan Allografts.
Biology of Blood and Marrow Transplantation
, 23
(5)
pp. 805-812.
10.1016/j.bbmt.2017.02.007.
|
Griffiths, PD;
Rothwell, E;
Raza, M;
Wilmore, S;
Doyle, T;
Harber, M;
O'Beirne, J;
... Emery, VC; + view all
(2017)
Correction: Randomized Controlled Trials to Define Viral Load Thresholds for Cytomegalovirus Pre-Emptive Therapy.
[Corrigendum].
PLOS ONo
, 12
(9)
, Article e0185298. 10.1371/journal.pone.0185298.
|
H
Hachani, R;
Birchall, MA;
Lowdell, MW;
Kasparis, G;
Tung, LD;
Manshian, BB;
Soenen, SJ;
... Thanh, NTK; + view all
(2017)
Assessing cell-nanoparticle interactions by high content imaging of biocompatible iron oxide nanoparticles as potential contrast agents for magnetic resonance imaging.
Scientific Reports
, 7
(1)
, Article 7850. 10.1038/s41598-017-08092-w.
|
Hartwig, T;
Montinaro, A;
von Karstedt, S;
Sevko, A;
Surinova, S;
Chakravarthy, A;
Taraborrelli, L;
... Walczak, H; + view all
(2017)
The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2.
Molecular Cell
, 65
(4)
pp. 730-742.
10.1016/j.molcel.2017.01.021.
|
Hotblack, AC;
(2017)
Characterising the role of dendritic cells in TCR gene therapy.
Doctoral thesis , UCL (University College London).
|
Hough, R;
Sandhu, S;
Khan, M;
Moran, A;
Feltbower, R;
Stiller, C;
Stevens, MCG;
... McCabe, MG; + view all
(2017)
Are survival and mortality rates associated with recruitment to clinical trials in teenage and young adult patients with acute lymphoblastic leukaemia? A retrospective observational analysis in England.
BMJ Open
, 7
(10)
, Article e017052. 10.1136/bmjopen-2017-017052.
|
Hughes, D;
Giugliani, R;
Guffon, N;
Jones, SA;
Mengel, KE;
Parini, R;
Matousek, R;
... Quartel, A; + view all
(2017)
Clinical outcomes in a subpopulation of adults with Morquio A syndrome: results from a long-term extension study of elosulfase alfa.
Orphanet Journal of Rare Diseases
, 12
, Article 98. 10.1186/s13023-017-0634-0.
|
Hughes, DA;
Nicholls, K;
Shankar, SP;
Sunder-Plassmann, G;
Koeller, D;
Nedd, K;
Vockley, G;
... Feldt-Rasmussen, U; + view all
(2017)
Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study.
Journal of Medical Genetics
, 54
(4)
pp. 288-296.
10.1136/jmedgenet-2016-104178.
|
I
Irshad, S;
Flores-Borja, F;
Lawler, K;
Monypenny, J;
Evans, R;
Male, V;
Gordon, P;
... Ng, T; + view all
(2017)
RORγt+ innate lymphoid cells promote lymph node metastasis of breast cancers.
Cancer Research
, 77
(5)
pp. 1083-1096.
10.1158/0008-5472.CAN-16-0598.
|
J
Jackson, LH;
Vlachodimitropoulou, E;
Shangaris, P;
Roberts, TA;
Ryan, TM;
Campbell-Washburn, AE;
David, AL;
... Stuckey, DJ; + view all
(2017)
Non-invasive MRI biomarkers for the early assessment of iron overload in a humanized mouse model of β-thalassemia.
Scientific Reports
, 7
, Article 43439. 10.1038/srep43439.
|
Jamal-Hanjani, M;
Wilson, GA;
McGranahan, N;
Birkbak, NJ;
Watkins, TBK;
Veeriah, S;
Shafi, S;
... Swanton, C; + view all
(2017)
Tracking the Evolution of Non-Small-Cell Lung Cancer.
New England Journal of Medicine
, 376
(22)
pp. 2109-2121.
10.1056/NEJMoa1616288.
|
Joshi, K;
Chain, BM;
Peggs, KS;
Quezada, SA;
(2017)
The "Achilles Heel" of Cancer and Its Implications for the Development of Novel Immunotherapeutic Strategies.
Cold Spring Harbor Perspectives in Medicine
10.1101/cshperspect.a027086.
(In press).
|
K
Kantarjian, H;
Stein, A;
Goekbuget, N;
Fielding, AK;
Schuh, AC;
Ribera, J-M;
Wei, A;
... Topp, MS; + view all
(2017)
Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia.
New England Journal of Medicine
, 376
(9)
pp. 836-847.
10.1056/NEJMoa1609783.
|
Kato, I;
Nishinaka, Y;
Nakamura, M;
Akarca, AU;
Niwa, A;
Ozawa, H;
Yoshida, K;
... Enver, T; + view all
(2017)
Hypoxic adaptation of leukemic cells infiltrating the CNS affords a therapeutic strategy targeting VEGFA.
Blood
, 129
(23)
pp. 3126-3129.
10.1182/blood-2016-06-721712.
|
Kirk, P;
Sheppard, M;
Carpenter, J-P;
Anderson, L;
He, T;
St Pierre, T;
Galanello, R;
... Pennell, DJ; + view all
(2017)
Post-mortem study of the association between cardiac iron and fibrosis in transfusion dependent anaemia.
Journal of Cardiovascular Magnetic Resonance
, 19
(1)
, Article 36. 10.1186/s12968-017-0349-3.
|
Knapper, S;
Russell, N;
Gilkes, A;
Hills, RK;
Gale, RE;
Cavenagh, JD;
Jones, G;
... Burnett, AK; + view all
(2017)
A randomised assessment of adding the kinase inhibitor lestaurtinib to 1st-line chemotherapy for FLT3-mutated AML.
Blood
, 129
(9)
pp. 1143-1154.
10.1182/blood-2016-07-730648.
|
Kozor, R;
Nordin, S;
Treibel, TA;
Rosmini, S;
Castelletti, S;
Fontana, M;
Captur, G;
... Moon, JC; + view all
(2017)
Insight into hypertrophied hearts: a cardiovascular magnetic resonance study of papillary muscle mass and T1 mapping.
European Heart Journal - Cardiovascular Imaging
, 18
(9)
pp. 1034-1040.
10.1093/ehjci/jew187.
|
Kramer, AM;
(2017)
Delineating the impact of binding-domain affinity and kinetic properties on Chimeric Antigen Receptor T-cell function.
Doctoral thesis , UCL (University College London).
|
Kühnl, A;
Cunningham, D;
Counsell, N;
Hawkes, EA;
Qian, W;
Smith, P;
Chadwick, N;
... Linch, D; + view all
(2017)
Outcome of Elderly Patients with Diffuse Large B-cell Lymphoma Treated with R-CHOP: Results from the UK NCRI R-CHOP14v21 trial with combined analysis of molecular characteristics with the DSHNHL RICOVER-60 trial.
Annals of Oncology
, 28
(7)
pp. 1540-1546.
10.1093/annonc/mdx128.
|
L
Latifoltojar, A;
Hall-Craggs, M;
Bainbridge, A;
Rabin, N;
Popat, R;
Rismani, A;
D'Sa, S;
... Punwani, S; + view all
(2017)
Whole-body MRI quantitative biomarkers are associated significantly with treatment response in patients with newly diagnosed symptomatic multiple myeloma following bortezomib induction.
European Radiology
10.1007/s00330-017-4907-8.
(In press).
|
Latifoltojar, A;
Hall-Craggs, M;
Rabin, N;
Popat, R;
Bainbridge, A;
Dikaios, N;
Sokolska, M;
... Yong, K; + view all
(2017)
Whole body magnetic resonance imaging in newly diagnosed multiple myeloma: early changes in lesional signal fat fraction predict disease response.
British Journal of Haematology
, 176
(2)
pp. 222-233.
10.1111/bjh.14401.
|
Lee, Doyoung;
(2017)
Investigation of mechanisms for enhancing expression of human FVIII in vitro; application to therapeutic protein production.
Doctoral thesis , UCL (University College London).
|
Lee, E;
Milan, A;
Urbani, L;
De Coppi, P;
Lowdell, MW;
(2017)
Decellularized material as scaffolds for tissue engineering studies in long gap esophageal atresia.
Expert Opinion on Biological Therapy
, 17
(5)
pp. 573-584.
10.1080/14712598.2017.1308482.
|
Lee, KCL;
Baker, L;
Mallett, S;
Riddell, A;
Chowdary, P;
Alibhai, H;
Chang, Y-M;
... Agarwal, B; + view all
(2017)
Hypercoagulability progresses to hypocoagulability during evolution of acetaminophen-induced acute liver injury in pigs.
Scientific Reports
, 7
(1)
, Article 9347. 10.1038/s41598-017-09508-3.
|
Lee, L;
Draper, B;
Chaplin, N;
Philip, B;
Chin, M;
Galas-Filipowicz, D;
Onuoha, S;
... Pule, M; + view all
(2017)
An APRIL based chimeric antigen receptor for dual targeting of BCMA and TACI in Multiple Myeloma.
Blood
, 2017
(5)
, Article 781351. 10.1182/blood-2017-05-781351.
|
Lee, LSH;
(2017)
APRIL based therapeutic strategies to target BCMA and TACI in multiple myeloma.
Doctoral thesis , UCL (University College London).
|
Li, Z;
Abraham, BJ;
Berezovskaya, A;
Farah, N;
Liu, Y;
Leon, T;
Fielding, A;
... Look, AT; + view all
(2017)
APOBEC signature mutation generates an oncogenic enhancer that drives LMO1 expression in T-ALL.
Leukemia
10.1038/leu.2017.75.
|
Linch, M;
Goh, G;
Hiley, C;
Shanmugabavan, Y;
McGranahan, N;
Rowan, A;
Wong, YNS;
... Swanton, C; + view all
(2017)
Intratumoural evolutionary landscape of high-risk prostate cancer: the PROGENY study of genomic and immune parameters.
Annals of Oncology
, 28
(10)
pp. 2472-2480.
10.1093/annonc/mdx355.
|
Llombart, V;
Alejandro Trejo, S;
Bronsoms, S;
Morancho, A;
Ma, F;
Faura, J;
Garcia-Berrocoso, T;
... Montaner, J; + view all
(2017)
Profiling and identification of new proteins involved in brain ischemia using MALDI-imaging-mass-spectrometry.
Journal of Proteomics
, 152
pp. 243-253.
10.1016/j.jprot.2016.11.014.
|
Lowdell, MW;
Thomas, A;
(2017)
The expanding role of the clinical haematologist in the new world of advanced therapy medicinal products.
British Journal of Haematology
, 176
(1)
pp. 9-15.
10.1111/bjh.14384.
|
M
Maccari, G;
Robinson, J;
Ballingall, K;
Guethlein, LA;
Grimholt, U;
Kaufman, J;
Ho, CS;
... Marsh, SG; + view all
(2017)
IPD-MHC 2.0: an improved inter-species database for the study of the major histocompatibility complex.
Nucleic Acids Research
, 45
(D1)
D860-D864.
10.1093/nar/gkw1050.
|
Maciocia, N;
Melville, A;
Cheesman, S;
Sharpley, F;
Ramasamy, K;
Streetly, M;
Jenner, M;
... Rabin, N; + view all
(2017)
Real-world use of pomalidomide and dexamethasone in double refractory multiple myeloma suggests benefit in renal impairment and adverse genetics: a multi-centre UK experience.
British Journal of Haematology
, 176
(6)
pp. 908-917.
10.1111/bjh.14547.
|
Maciocia, PM;
(2017)
Targeting the T-cell Receptor Beta Constant Region for Investigation and Immunotherapy of T-cell Malignancies.
Doctoral thesis , UCL (University College London).
|
Maciocia, PM;
Wawrzyniecka, PA;
Akarca, AU;
Philip, B;
Ricciardelli, I;
Somja, J;
Onuoha, SC;
... Pule, MA; + view all
(2017)
Targeting T-cell receptor β-constant region for immunotherapy of T-cell malignancies.
Nature Medicine
, 23
(12)
pp. 1416-1423.
10.1038/nm.4444.
|
Marlein, CR;
Zaitseva, L;
Piddock, RE;
Robinson, SD;
Edwards, DR;
Shafat, MS;
Zhou, Z;
... Rushworth, SA; + view all
(2017)
NADPH oxidase-2 derived superoxide drives mitochondrial transfer from bone marrow stromal cells to leukemic blasts.
Blood
, 130
(14)
pp. 1649-1660.
10.1182/blood-2017-03-772939.
|
Martinelli, G;
Boissel, N;
Chevallier, P;
Ottmann, O;
Goekbuget, N;
Topp, MS;
Fielding, AK;
... Stein, A; + view all
(2017)
Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome-Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter Study.
Journal of Clinical Oncology
, 35
(16)
pp. 1795-1802.
10.1200/JCO.2016.69.3531.
|
Martinez, C;
Gayoso, J;
Canals, C;
Finel, H;
Peggs, K;
Dominietto, A;
Castagna, L;
... Sureda, A; + view all
(2017)
Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation as Alternative to Matched Sibling or Unrelated Donor Transplantation for Hodgkin Lymphoma: A Registry Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation.
Journal of Clinical Oncology
, 35
(30)
pp. 3425-3432.
10.1200/JCO.2017.72.6869.
|
Matalonga, J;
Glaria, E;
Bresque, M;
Escande, C;
Carbó, JM;
Kiefer, K;
Vicente, R;
... Valledor, AF; + view all
(2017)
The Nuclear Receptor LXR Limits Bacterial Infection of Host Macrophages through a Mechanism that Impacts Cellular NAD Metabolism.
Cell Reports
, 18
(5)
pp. 1241-1255.
10.1016/j.celrep.2017.01.007.
|
Mattar, CNZ;
Gil-Farina, I;
Rosales, C;
Johana, N;
Tan, YYW;
McIntosh, J;
Kaeppel, C;
... Chan, JKY; + view all
(2017)
In Utero Transfer of Adeno-Associated Viral Vectors Produces Long-Term Factor IX Levels in a Cynomolgus Macaque Model.
Molecular Therapy
, 25
(8)
pp. 1843-1853.
10.1016/j.ymthe.2017.04.003.
|
Maughan, EF;
Hynds, RE;
Proctor, TJ;
Janes, SM;
Elliott, M;
Birchall, MA;
Lowdell, MW;
(2017)
Autologous Cell Seeding in Tracheal Tissue Engineering.
Current Stem Cell Reports
, 3
(4)
pp. 279-289.
10.1007/s40778-017-0108-2.
|
Mavroudis, CA;
Eleftheriou, D;
Hong, Y;
Majumder, B;
Koganti, S;
Sapsford, R;
North, J;
... Rakhit, RD; + view all
(2017)
Microparticles in acute coronary syndrome.
Thrombosis Research
, 156
pp. 109-116.
10.1016/j.thromres.2017.06.003.
|
McGranahan, N;
Rosenthal, R;
Hiley, CT;
Rowan, AJ;
Watkins, TBK;
Wilson, GA;
Birkbak, NJ;
... Swanton, C; + view all
(2017)
Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution.
Cell
10.1016/j.cell.2017.10.001.
(In press).
|
McNamara, MG;
Bridgewater, J;
Lopes, A;
Wasan, H;
Malka, D;
Jensen, LH;
Okusaka, T;
... Valle, JW; + view all
(2017)
Systemic therapy in younger and elderly patients with advanced biliary cancer: sub-analysis of ABC-02 and twelve other prospective trials.
BMC Cancer
, 17
, Article 262. 10.1186/s12885-017-3266-9.
|
Megias, D;
Phillips, M;
Clifton-Hadley, L;
Harron, E;
Eaton, DJ;
Sanghera, P;
Whitfield, G;
(2017)
Dose specification for hippocampal sparing whole brain radiotherapy (HS WBRT): considerations from the UK HIPPO trial QA programme.
British Journal Of Radiology
, 90
(1071)
, Article 20160829. 10.1259/bjr.20160829.
|
Mehta, A;
Belmatoug, N;
Bembi, B;
Deegan, P;
Elstein, D;
Göker-Alpan, Ö;
Lukina, E;
... Hughes, D; + view all
(2017)
Exploring the patient journey to diagnosis of Gaucher disease from the perspective of 212 patients with Gaucher disease and 16 Gaucher expert physicians.
Molecular Genetics and Metabolism
, 122
(3)
pp. 122-129.
10.1016/j.ymgme.2017.08.002.
|
Miller, PDE;
de Silva, T;
Skinner, R;
Gilleece, M;
Peniket, A;
Hamblin, A;
Greenfield, D;
... Snowden, JA; + view all
(2017)
Routine vaccination practice after adult and paediatric allogeneic haematopoietic stem cell transplant: a survey of UK NHS programmes.
Bone Marrow Transplantation
, 52
pp. 775-777.
10.1038/bmt.2016.362.
|
Mlcochova, P;
Sutherland, KA;
Watters, SA;
Bertoli, C;
de Bruin, RAM;
Rehwinkel, J;
Neil, SJ;
... Gupta, RK; + view all
(2017)
A G1-like state allows HIV-1 to bypass SAMHD1 restriction in macrophages.
The EMBO Journal
, 36
(5)
pp. 604-616.
10.15252/embj.201696025.
|
Morris, EC;
Fox, T;
Chakraverty, R;
Tendeiro, R;
Snell, K;
Rivat, C;
Grace, S;
... Thrasher, AJ; + view all
(2017)
Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult.
Blood
, 130
pp. 1327-1335.
10.1182/blood-2017-04-777136.
|
N
Nathwani, AC;
Davidoff, AM;
Tuddenham, EGD;
(2017)
Advances in Gene Therapy for Haemophilia.
Hum Gene Ther
10.1089/hum.2017.167.
|
Nathwani, AC;
Davidoff, AM;
Tuddenham, EGD;
(2017)
Gene Therapy for Hemophilia.
Hematology/Oncology Clinics of North America
, 31
(5)
pp. 853-868.
10.1016/j.hoc.2017.06.011.
|
Ngwenya, N;
Kenten, C;
Jones, L;
Gibson, F;
Pearce, S;
Flatley, M;
Hough, R;
... Whelan, J; + view all
(2017)
Experiences and Preferences for End-of-Life Care for Young Adults with Cancer and Their Informal Carers: A Narrative Synthesis.
Journal of Adolescent and Young Adult Oncology
, 6
(2)
pp. 200-212.
10.1089/jayao.2016.0055.
|
Nienhuis, AW;
Nathwani, AC;
Davidoff, AM;
(2017)
Gene Therapy for Hemophilia.
[Review].
Molecular Therapy
, 25
(5)
pp. 1163-1167.
10.1016/j.ymthe.2017.03.033.
|
O
O'Connor, D;
Moorman, AV;
Wade, R;
Hancock, J;
Tan, RMR;
Bartram, J;
Moppett, J;
... Samarasinghe, S; + view all
(2017)
Use of Minimal Residual Disease Assessment to Redefine Induction Failure in Pediatric Acute Lymphoblastic Leukemia.
Journal of Clinical Oncology
, 35
(6)
pp. 660-667.
10.1200/JCO.2016.69.6278.
|
P
Pastores, GM;
Hughes, DA;
(2017)
Lysosomal Storage Disorders and Malignancy.
Diseases
, 5
(1)
10.3390/diseases5010008.
|
Porter, JB;
Cappellini, MD;
Kattamis, A;
Viprakasit, V;
Musallam, KM;
Zhu, Z;
Taher, AT;
(2017)
Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.
British Journal of Haematology
, 176
(2)
pp. 288-299.
10.1111/bjh.14373.
|
Porter, JB;
Elalfy, M;
Taher, A;
Aydinok, Y;
Lee, SH;
Sutcharitchan, P;
El-Ali, A;
... El-Beshlawy, A; + view all
(2017)
Limitations of serum ferritin to predict liver iron concentration responses to deferasirox therapy in patients with transfusion-dependent thalassaemia.
European Journal of Haematology
, 98
(3)
pp. 280-288.
10.1111/ejh.12830.
|
Post, M;
Cuapio, A;
Osl, M;
Lehmann, D;
Resch, U;
Davies, DM;
Bilban, M;
... Hofer, E; + view all
(2017)
The Transcription Factor ZnF683/hOBiT regulates human NK-cell Development.
Frontiers in Immunology
, 8
, Article 535. 10.3389/fimmu.2017.00535.
|
Pugh, G;
Hough, R;
Gravestock, H;
Williams, K;
Fisher, A;
(2017)
Lifestyle advice provision to teenage and young adult cancer patients: the perspective of health professionals in the UK.
Support Care in Cancer
, 25
(12)
pp. 3823-3832.
10.1007/s00520-017-3814-5.
|
Pugh, G;
Hough, RE;
Gravestock, HL;
Jackson, SE;
Fisher, A;
(2017)
The Health Behavior Information Needs and Preferences of Teenage and Young Adult Cancer Survivors.
Journal of Adolescent and Young Adult Oncology
, 6
(2)
pp. 318-326.
10.1089/jayao.2016.0089.
|
Pugh, S;
Thiébaut, R;
Bridgewater, J;
Grisoni, ML;
Moutasim, K;
Rousseau, F;
Thomas, GJ;
... Laurent-Puig, P; + view all
(2017)
Association between miR-31-3p expression and cetuximab efficacy in patients with KRAS wild-type metastatic colorectal cancer: A post-hoc analysis of the New EPOC trial.
Oncotarget
, 8
(55)
pp. 93856-93866.
10.18632/oncotarget.21291.
|
Q
Qasim, W;
Zhan, H;
Samarasinghe, S;
Adams, S;
Amrolia, P;
Stafford, S;
Butler, K;
... Veys, P; + view all
(2017)
Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells.
Science Translational Medicine
, 9
(374)
, Article eaaj2013. 10.1126/scitranslmed.aaj2013.
|
R
Radford, J;
McKay, P;
Malladi, R;
Johnson, R;
Bloor, A;
Percival, F;
Sureda, A;
(2017)
Treatment pathways and resource use associated with recurrent Hodgkin lymphoma after autologous stem cell transplantation.
Bone Marrow Transplant
, 52
pp. 452-454.
10.1038/bmt.2016.244.
|
Rahman, S;
Magnussen, M;
León, TE;
Farah, N;
Li, Z;
Abraham, BJ;
Alapi, KZ;
... Mansour, MR; + view all
(2017)
Activation of the LMO2 oncogene through a somatically acquired neomorphic promoter in T-cell acute lymphoblastic leukemia.
Blood
, 129
(24)
pp. 3221-3226.
10.1182/blood-2016-09-742148.
|
Reed, M;
(2017)
Characterisation of pathogenic pathways within the bone microenvironment of Gaucher Disease which contribute to bone pathology and haematological malignancy.
Doctoral thesis , UCL (University College London).
|
Robinson, J;
Guethlein, LA;
Cereb, N;
Yang, SY;
Norman, PJ;
Marsh, SGE;
Parham, P;
(2017)
Distinguishing functional polymorphism from random variation in the sequences of >10,000 HLA-A, -B and -C alleles.
PLoS Genetics
, 13
(6)
, Article e1006862. 10.1371/journal.pgen.1006862.
|
Roddie, C;
Peggs, KS;
(2017)
Immunotherapy for transplantation-associated viral infections.
Journal Of Clinical Investigation
, 127
(7)
pp. 2513-2522.
10.1172/JCI90599.
|
Rossig, C;
Pule, M;
Altvater, B;
Saiagh, S;
Wright, G;
Ghorashian, S;
Clifton-Hadley, L;
... Amrolia, PJ; + view all
(2017)
Vaccination to improve the persistence of CD19CAR gene-modified T cells in relapsed pediatric acute lymphoblastic leukemia.
Leukemia
, 31
pp. 1087-1095.
10.1038/leu.2017.39.
|
Russell, LJ;
Jones, L;
Enshaei, A;
Tonin, S;
Ryan, SL;
Eswaran, J;
Nakjang, S;
... Harrison, CJ; + view all
(2017)
Characterisation of the genomic landscape of CRLF2-rearranged acute lymphoblastic leukemia.
Genes, Chromosomes and Cancer
, 56
(5)
pp. 363-372.
10.1002/gcc.22439.
|
S
Schiffmann, R;
Hughes, DA;
Linthorst, GE;
Ortiz, A;
Svarstad, E;
Warnock, DG;
West, ML;
(2017)
Screening, diagnosis, and management of patients with Fabry disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
Kidney International
, 91
(2)
pp. 284-293.
10.1016/j.kint.2016.10.004.
|
Schoser, B;
Fong, E;
Geberhiwot, T;
Hughes, D;
Kissel, JT;
Madathil, SC;
Orlikowski, D;
... Young, P; + view all
(2017)
Maximum inspiratory pressure as a clinically meaningful trial endpoint for neuromuscular diseases: a comprehensive review of the literature.
[Review].
Orphanet Journal of Rare Diseases
, 12
, Article 52. 10.1186/s13023-017-0598-0.
|
Shafat, MS;
Oellerich, T;
Mohr, S;
Robinson, SD;
Edwards, DR;
Marlein, CR;
Piddock, RE;
... Rushworth, SA; + view all
(2017)
Leukemic blasts program bone marrow adipocytes to generate a protumoral microenvironment.
Blood
, 129
(10)
pp. 1320-1332.
10.1182/blood-2016-08-734798.
|
Shaw, BE;
Mayor, NP;
Szydlo, RM;
Bultitude, WP;
Anthias, C;
Kirkland, K;
Perry, J;
... Marsh, SG; + view all
(2017)
Recipient/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplants.
Bone Marrow Transplant
, 52
pp. 717-725.
10.1038/bmt.2016.352.
|
Siddharthan, T;
Grigsby, M;
Miele, CH;
Bernabe-Ortiz, A;
Miranda, JJ;
Gilman, RH;
Wise, RA;
... Checkley, W; + view all
(2017)
Prevalence and risk factors of restrictive spirometry in a cohort of Peruvian adults.
The International Journal of Tuberculosis and Lung Disease
, 21
(9)
pp. 1062-1068.
10.5588/ijtld.17.0101.
|
Singer, R;
Campbell, P;
Fernandes, C;
Statham, P;
Hochhauser, D;
Bridgewater, J;
(2017)
Time to endoscopic intervention in patients with upper gastrointestinal patients can be improved with pathway provision.
BMC Cancer
, 17
, Article 365. 10.1186/s12885-017-3335-0.
|
Snowden, JA;
Greenfield, DM;
Bird, JM;
Boland, E;
Bowcock, S;
Fisher, A;
Low, E;
... UK Myeloma Forum (UKMF) and the British Society for Haematology, .; + view all
(2017)
Guidelines for screening and management of late and long-term consequences of myeloma and its treatment.
British Journal of Haematology
, 176
(6)
pp. 888-907.
10.1111/bjh.14514.
|
T
Taher, AT;
Origa, R;
Perrotta, S;
Kourakli, A;
Ruffo, GB;
Kattamis, A;
Goh, AS;
... Porter, JB; + view all
(2017)
New film-coated tablet formulation of deferasirox is well tolerated in patients with thalassemia or lower-risk MDS: Results of the randomized, phase II ECLIPSE study.
American Journal of Hematology
, 92
(5)
pp. 420-428.
10.1002/ajh.24668.
|
Taieb, J;
Kourie, HR;
Emile, J-F;
Le Malicot, K;
Balogoun, R;
Tabernero, J;
Mini, E;
... Pan-European Trials in Alimentary Tract Cancer (PETACC)-8 Invest; + view all
(2017)
Association of Prognostic Value of Primary Tumor Location in Stage III Colon Cancer With RAS and BRAF Mutational Status.
JAMA Oncology
10.1001/jamaoncol.2017.3695.
(In press).
|
Tailor, H;
Mackie, I;
Mellick, A;
Machin, S;
(2017)
Evaluation of the Sysmex XN-550, a Novel Compact Haematology analyser from the XN-L (R) series, compared to the XN-20 system.
International Journal of Laboratory Hematology
, 39
(6)
pp. 585-589.
10.1111/ijlh.12701.
|
Taylor, SA;
Mallett, S;
Miles, A;
Beare, S;
Bhatnagar, G;
Bridgewater, J;
Glynne-Jones, R;
... Halligan, S; + view all
(2017)
Streamlining staging of lung and colorectal cancer with whole body MRI; study protocols for two multicentre, non-randomised, single-arm, prospective diagnostic accuracy studies (Streamline C and Streamline L).
BMC Cancer
, 17
, Article 299. 10.1186/s12885-017-3281-x.
|
Tostoes, R;
Dodgson, J;
Weil, B;
Gerontas, S;
Mason, C;
Veraitch, FS;
(2017)
A novel filtration system for point of care washing of cellular therapy products.
Journal of Tissue Engineering and Regenerative Medicine
, 11
(11)
pp. 3157-3167.
10.1002/term.2225.
|
Tuddenham, EG;
(2017)
Platelets are a safe way to deliver factor VIII. After 13 years of preclinical research it is now time for a clinical trial.
Journal of Thrombosis and Haemostasis
, 15
(1)
pp. 96-97.
10.1111/jth.13545.
|
Turajlic, S;
Litchfield, K;
Xu, H;
Rosenthal, R;
McGranahan, N;
Reading, JL;
Wong, YNS;
... Swanton, C; + view all
(2017)
Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis.
The Lancet Oncology
, 18
(8)
pp. 1009-1021.
10.1016/S1470-2045(17)30516-8.
|
V
Vargas, FA;
Furness, AJS;
Solomon, I;
Joshi, K;
Mekkaoui, L;
Lesko, MH;
Rota, EM;
... Quezada, SA; + view all
(2017)
Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors.
Immunity
, 46
(4)
pp. 577-586.
10.1016/j.immuni.2017.03.013.
|
Vlachodimitropoulou, E;
Chen, Y-L;
Garbowski, M;
Koonyosying, P;
Psaila, B;
Sola-Visner, M;
Cooper, N;
... Porter, J; + view all
(2017)
Eltrombopag: a powerful chelator of cellular or extracellular iron(III) alone or combined with a second chelator.
Blood
, 130
(17)
pp. 1923-1933.
10.1182/blood-2016-10-740241.
|
Vos, JM;
Notermans, NC;
D'Sa, S;
Lunn, MP;
van der Pol, WL;
Kraan, W;
Reilly, MM;
... Minnema, MC; + view all
(2017)
High prevalence of the MYD88 L265P mutation in IgM anti-MAG paraprotein-associated peripheral neuropathy.
[Letter].
Journal of Neurology, Neurosurgery & Psychiatry
, 89
(9)
pp. 1007-1009.
10.1136/jnnp-2017-316689.
|
W
Weil, BD;
(2017)
Purification Of Progenitor Photoreceptors Derived From The Directed Differentiation Of Human Pluripotent Stem Cells.
Doctoral thesis , UCL (University College London).
|
Weil, BD;
Jenkins, MJ;
Uddin, S;
Bracewell, DG;
Wellings, D;
Farid, SS;
Veraitch, F;
(2017)
An integrated experimental and economic evaluation of cell therapy affinity purification technologies.
Regenerative Medicine
, 12
(4)
pp. 397-417.
10.2217/rme-2016-0156.
|
Wong, YNS;
Joshi, K;
Pule, M;
Peggs, KS;
Swanton, C;
Quezada, SA;
Linch, M;
(2017)
Evolving adoptive cellular therapies in urological malignancies.
Lancet Oncology
, 18
(6)
E341-E353.
10.1016/S1470-2045(17)30327-3.
|
Wood, G;
Grenader, T;
Nash, S;
Adams, R;
Kaplan, R;
Fisher, D;
Maughan, T;
(2017)
Derived neutrophil to lymphocyte ratio as a prognostic factor in patients with advanced colorectal cancer according to RAS and BRAF status: a post-hoc analysis of the MRC COIN study.
Anti-Cancer Drugs
, 28
(5)
pp. 546-550.
10.1097/CAD.0000000000000488.
|
Y
Yang, J;
Milasta, S;
Hu, D;
AlTahan, AM;
Interiano, RB;
Zhou, J;
Davidson, J;
... Davidoff, AM; + view all
(2017)
Targeting Histone Demethylases in MYC-Driven Neuroblastomas with Ciclopirox.
Cancer Research
, 77
(17)
pp. 4626-4638.
10.1158/0008-5472.CAN-16-0826.
|